2.86 USD
↘ 0.05 (1.72%)LIVE (AS OF 03:09 PM EDT)
NRX Pharmaceuticals, Inc. Common Stock
NRXPNASDAQ • USD
Market: OPEN
NRX Pharmaceuticals, Inc. Common Stock (NRXP) is currently trading at $2.86. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (13811.8%) and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 2, 2026.
Open?$2.91
High?$3.05
Low?$2.79
Prev. Close?$2.91
Volume?550.0K
Avg. Volume?673.6K
VWAP?$2.84
Rel. Volume?0.82x
Bid / Ask
Bid?$2.84 × 200
Ask?$2.85 × 600
Spread?$0.01
Midpoint?$2.84
Valuation & Ratios
Market Cap?126.0M
Shares Out?43.3M
Float?31.0M
Float %?85.6%
P/E Ratio?N/A
P/B Ratio?-741.12
EPS?-$0.54
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Address
1201 ORANGE STREET
WILMINGTON, DE 19801
Phone: 484-254-6134
WILMINGTON, DE 19801
Phone: 484-254-6134
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?60
Short Sent.?25
Piotroski F-Score?0/9Weak
Altman Z-Score?-13.10Distress
Confidence?51%Low
Short InterestSqueeze Risk
Short % of Float?31.52%Squeeze Risk
Short Interest?9.8M
Days to Cover?16.3
Free Float31.0M
Avg Daily Volume600.6K
Settlement Date2026-09-15
Financial Health
Current Ratio?0.86Weak
Quick Ratio?0.86Weak
Cash Ratio?0.79Adequate
Debt/Equity?-2.42Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-741.12CHEAP▾
S&P97
P/S?37.12HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-5.1CHEAP▾
S&P97
EV/Sales?29.38HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?13,811.8%STRONG▾
Peers50
S&P97
ROA?-68.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-20671000
Enterprise Value?$99.7M
Fundamentals ratios updated end of day